Trials / Recruiting
RecruitingNCT07411443
AI-Enhanced Imaging in Population Breast Cancer Screening
Population-based Breast Cancer Screening Study Using AI-Assisted Imaging Technology
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16,000 (estimated)
- Sponsor
- Fudan University · Academic / Other
- Sex
- Female
- Age
- 35 Years – 69 Years
- Healthy volunteers
- Accepted
Summary
Artificial Intelligence (AI)-assisted imaging technologies (including AI-assisted breast ultrasound and AI-assisted mammography) can effectively improve the accuracy and efficiency of breast imaging examinations, but their application in large-scale population-based breast cancer screening remains very limited. This project aims to improve the effectiveness and feasibility of breast cancer screening by addressing the core issues and bottlenecks in population-based breast cancer screening. We will conduct a prospective cluster-controlled screening trial in the general population, with district-based cluster grouping. The intervention group will undergo combined screening using AI-assisted ultrasound plus AI-assisted mammography, while the control group will receive conventional screening: breast ultrasound for initial screening and mammography for secondary screening. Based on population screening practices, we will evaluate the effectiveness of AI-assisted imaging diagnostic technology in various technical aspects of actual screening and perform cost-effectiveness analyses. This study will investigate the application of AI-assisted breast imaging technology in population-based breast cancer screening, providing scientific evidence for the large-scale implementation of AI-assisted imaging technologies. Furthermore, by combining population screening practices with model simulations, we will explore multi-dimensional breast cancer screening strategies to optimize screening approaches and technologies for the Chinese population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AI-assisted screening | The intervention group will undergo combined screening using AI-assisted ultrasound plus AI-assisted mammography |
Timeline
- Start date
- 2025-01-01
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
- First posted
- 2026-02-13
- Last updated
- 2026-02-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07411443. Inclusion in this directory is not an endorsement.